
浏览全部资源
扫码关注微信
西安交通大学第一附属医院榆林医院麻醉科,陕西榆林
王丹丹,E-mail:wangdandan2025@163.com
收稿:2026-06-10,
修回:2026-08-03,
录用:2026-08-05,
纸质出版:2026-09-30
移动端阅览
张慧,徐反宁,李丹,等.单次静脉注射小剂量瑞马唑仑降低剖宫产术后寒战风险并促进术后恢复:一项随机双盲对照试验[J].陆军军医大学学报,2026,48(18):2656-2664.DOI:10.16016/j.2097-0927.202606045.
Zhang H,Xu F N,Li D,et al.Single-dose intravenous remimazolam reduces risk of post-cesarean shivering and promotes postoperative recovery: a randomized double-blind controlled trial[J].J Army Med Univ,2026,48(18):2656-2664.DOI:10.16016/j.2097-0927.202606045.
张慧,徐反宁,李丹,等.单次静脉注射小剂量瑞马唑仑降低剖宫产术后寒战风险并促进术后恢复:一项随机双盲对照试验[J].陆军军医大学学报,2026,48(18):2656-2664.DOI:10.16016/j.2097-0927.202606045. DOI:
Zhang H,Xu F N,Li D,et al.Single-dose intravenous remimazolam reduces risk of post-cesarean shivering and promotes postoperative recovery: a randomized double-blind controlled trial[J].J Army Med Univ,2026,48(18):2656-2664.DOI:10.16016/j.2097-0927.202606045. DOI:
目的
2
腰硬联合麻醉下剖宫产术后寒战发生率高,会导致产妇不适、增加氧耗、干扰生命体征监测,甚至引发不良心血管及呼吸事件。瑞马唑仑(新型超短效苯二氮䓬类药物)在全身麻醉中可降低术后寒战发生率,本研究旨在评估瑞马唑仑对腰硬联合麻醉下剖宫产术后寒战的预防效果及对产妇术后恢复质量的影响。
方法
2
采用前瞻性随机双盲安慰剂对照研究设计方案,选取2025年6—12月在西安交通大学第一附属医院榆林医院行择期腰硬联合麻醉下剖宫产术的单胎足月产妇140例(年龄24~40岁,ASA Ⅱ级,BMI≤35 kg/m²),随机分配至瑞马唑仑(Remimazolam,胎儿娩出夹闭脐带后静脉注射瑞马唑仑0.2 mg/kg)组和对照(Control,给予等容量生理盐水)组(
n
=70)。采用床旁寒战评估量表BSAS评估2组椎管内麻醉后90 min内中重度寒战发生率,术后1、2 d恢复质量(包括情绪状态、心理支持、身体舒适度、身体独立性和疼痛5个维度量表)、给药后90 min内警觉/镇静评估(OAA/S)评分及术中不良反应(低血压、心动过缓、恶心、呕吐、头晕)等指标。
结果
2
2组产妇年龄、体质量、孕周、初产妇比率、麻醉阻滞平面、术中失血量及手术时长等基线资料差异均无统计学意义(
P
>
0.05)。①主要结局事件:Remimazolam组中重度寒战总发生率为27.1%(19/70),显著低于Control组的55.7%(39/70,
P
<
0.001);与Control组相比,Remimazolam组发生中重度寒战的风险降低62%(
HR
=0.38,95%
CI
:0.22~0.67,
P
=0.000 4);0~30 min时段Remimazolam组中重度寒战发生率(10.0%)显著低于Control组(25.7%,
P
=0.027)。
②次要结局事件:术后1 d QoR-15总分Remimazolam组为126(124,128)分,显著高于Control组的116(115,118)分(
P
<
0.001);术后2 d Remimazolam组为141(140,143)分,显著高于Control组的133(130,135)分(
P
<
0.001)。其中Remimazolam组在情绪状态、心理支持、身体舒适度3个维度评分均高于Control组(均
P
<
0.001),2组在身体独立性和疼痛维度评分差异无统计学意义(
P
>
0.05)。Remimazolam组给药后15 min OAA/S评分为5(4,5)分,低于Control组的5(5,5)分(
P
=0.004),30 min后恢复至对照组水平(
P
>
0.05)。2组心动过缓、低血压、恶心、呕吐及头晕等不良反应发生率差异均无统计学意义(均
P
>
0.05)。
结论
2
腰硬联合麻醉下剖宫产术中胎儿娩出后单次静脉注射0.2 mg/kg瑞马唑仑,可使术后中重度寒战风险降低62%,同时可显著改善产妇术后1、2 d的恢复质量(尤其在情绪状态、心理支持和身体舒适度维度),且仅产生轻度、可逆的术中镇静作用,不增加不良反应风险。
Objective
2
Post-cesarean shivering under combined spinal-epidural anesthesia (CSEA) is highly prevalent
which can cause to maternal discomfort
increase oxygen consumption
interfere with vital sign monitoring
and potentially lead to adverse cardiovascular and respiratory events. Remimazolam
a novel ultrashort-acting benzodiazepine
has been shown to reduce postoperative shivering in general anesthesia. This study aims to evaluate the prophylactic effect of remimazolam on post-cesarean shivering under CSEA and its impact on maternal recovery quality.
Methods
2
A prospective randomized double-blind placebo-controlled trial was conducted on 140 singleton full-term parturients (aged 24-40 years
ASA physical status II
BMI ≤35 kg/m²) undergoing elective cesarean section under CSEA in our hospital from June to December 2025. They were randomly assigned to a remimazolam group (Group Remimazolam
receiving a single intravenous injection of remimazolam 0.2 mg/kg immediately after delivery and umbilical cord clamping
n
=70) and a control group (Group Control
n
=70
receiving an equal volume of normal saline). The incidence of moderate-to-severe shivering within 90 min after neuraxial anesthesia
[assessed using the Bedside Shivering Assessment Scale (BSAS)
]
. quality of recovery on postoperative days 1 and 2 [measured by the 15-item Quality of Recovery (QoR-15) scale
covering 5 dimensions: emotional state
psychological support
physical comfort
physical independence
and pain
]
Observer's Assessment of Alertness/Sedation (OAA/S) scores within 90 min after drug administration
and intraoperative adverse reactions (hypotension
bradycardia
nausea. vomiting and dizziness) were compared between the 2 groups.
Results
2
There were no statistically significant differences in baseline characteristics between the 2 groups
including age
body weight
gestational age
primipara ratio
anesthetic block level
intraoperative blood loss
or operative duration (all
P
>
0.05). ① For the primary outcome
the overall incidence of moderate-to-severe shivering in Group Remimazolam was 27.1% (19/70)
significantly lower than that in Group Control [55.7% (39/70)
P
<
0.001
]
. Remimazolam reduced the risk of moderate-to-severe shivering by 62% compared with the risk in the Group Control (
HR
=0.38
95%
CI
: 0.22 to 0.67
P
=0.000 4). During the 0-30 min period
the incidence of moderate-to-severe shivering was significantly lower in Group Remimazolam than in Group Control (10.0%
vs
25.7%
P
=0.027). ②For secondary outcomes
the QoR-15 total score on postoperative day 1 was 126 (124
128) in Group Remimazolam
which was significantly higher than that in the Control group [116 (115
118)
P
<
0.001
]
; on postoperative day 2
the Remimazolam group scored 141 (140
143)
which was significantly higher than that in the Control group [133 (130
135)
P
<
0.001
]
. Group Remimazolam showed significantly higher scores in the dimensions of emotional state
psychological support
and physical comfort (all
P
<
0.001)
whereas there were no sta
tistically significant differences between the 2 groups in the dimensions of physical independence or pain (
P
>
0.05). The OAA/S score at 15 min after drug administration in the Remimazolam group was 5(4
5)
which was lower than that in the Control group [5 (5
5)
P
=0.004
]
and returned to the level of the control group after 30 min (
P
>
0.05). No significant differences were observed in the incidence of bradycardia
hypotension
nausea
vomiting or dizzines between the 2 groups (all
P
>
0.05).
Conclusion
2
A single intravenous dose of 0.2 mg/kg remimazolam administered immediately after delivery during cesarean section under CSEA can significantly reduce the risk of moderate-to-severe post-cesarean shivering by 62%
also improve the quality of maternal recovery on postoperative days 1 and 2 (particularly in the dimensions of emotional state
psychological support
and physical comfort). The regimen produces only mild
reversible intraoperative sedation without increasing the risk of adverse reactions.
Crowley L J , Buggy D J . Shivering and neuraxial anesthesia [J]. Reg Anesth Pain Med , 2008 , 33 ( 3 ): 241 - 252 . DOI: 10.1136/rapm-00115550-200805000-00009 http://dx.doi.org/10.1136/rapm-00115550-200805000-00009 .
Zhang Y W , Zhang J , Hu J Q , et al . Neuraxial adjuvants for prevention of perioperative shivering during cesarean section: a network meta-analysis following the PRISMA guidelines [J]. World J Clin Cases , 2019 , 7 ( 16 ): 2287 - 2301 . DOI: 10.12998/wjcc.v7.i16.2287 http://dx.doi.org/10.12998/wjcc.v7.i16.2287 .
Zhuo Q , Xu J B , Zhang J , et al . Effect of active and passive warming on preventing hypothermia and shivering during cesarean delivery: a systematic review and meta-analysis of randomized controlled trials [J]. BMC Pregnancy Childbirth , 2022 , 22 ( 1 ): 720 . DOI: 10.1186/s12884-022-05054-7 http://dx.doi.org/10.1186/s12884-022-05054-7 .
Kumar K , Lin C , Symons T , et al . Narrative review on perioperative shivering during Caesarean section under neuraxial anaesthesia [J]. Rom J Anaesth Intensive Care , 2022 , 29 ( 1 ): 41 - 46 . DOI: 10.2478/rjaic-2022-0006 http://dx.doi.org/10.2478/rjaic-2022-0006 .
Liu J , Wang Y , Ma W H . Shivering prevention and treatment during cesarean delivery under neuraxial anesthesia: a systematic review [J]. Minerva Anestesiol , 2018 , 84 ( 12 ): 1393 - 1405 . DOI: 10.23736/S0375-9393.18.12478-3 http://dx.doi.org/10.23736/S0375-9393.18.12478-3 .
Li Y Z , Jiang Y , Lin H , et al . Subarachnoid and epidural dexmedetomidine for the prevention of post-anesthetic shivering: a meta-analysis and systematic review [J]. Drug Des Devel Ther , 2019 , 13 : 3785 - 3798 . DOI: 10.2147/DDDT.S204411 http://dx.doi.org/10.2147/DDDT.S204411 .
Colin P J , Bichajian L H , Curt V R , et al . Pharmacokinetics and pharmacodynamics of remimazolam for procedural sedation in children and adolescents [J]. Anesthesiology , 2025 , 143 ( 2 ): 368 - 382 . DOI: 10.1097/ALN.0000000000005560 http://dx.doi.org/10.1097/ALN.0000000000005560 .
Lee J M , Park Y , Ahn D W , et al . Remimazolam, a novel drug, for safe and effective endoscopic sedation [J]. Clin Endosc , 2025 , 58 ( 3 ): 370 - 376 . DOI: 10.5946/ce.2024.026 http://dx.doi.org/10.5946/ce.2024.026 .
Zhou Y Y , Yang S T , Duan K M , et al . Efficacy and safety of remimazolam besylate in bronchoscopy for adults: a multicenter, randomized, double-blind, positive-controlled clinical study [J]. Front Pharmacol , 2022 , 13 : 1005367 . DOI: 10.3389/fphar.2022.1005367 http://dx.doi.org/10.3389/fphar.2022.1005367 .
Lee C , Lee C , Lee J , et al . Comparison of core body temperatures in patients administered remimazolam or propofol during robotic-assisted and laparoscopic radical prostatectomy [J]. Medicina (Kaunas) , 2022 , 58 ( 5 ): 690 . DOI: 10.3390/medicina58050690 http://dx.doi.org/10.3390/medicina58050690 .
Gu W J , Liu J C . Ondansetron and shivering during cesarean delivery under combined spinal epidural anesthesia: a live issue [J]. Reg Anesth Pain Med , 2013 , 38 ( 3 ): 252 . DOI: 10.1097/AAP.0b013e318289efaa http://dx.doi.org/10.1097/AAP.0b013e318289efaa .
Sessler D I . Perioperative thermoregulation and heat balance [J]. Lancet , 2016 , 387 ( 10038 ): 2655 - 2664 . DOI: 10.1016/S0140-6736(15)00981-2 http://dx.doi.org/10.1016/S0140-6736(15)00981-2 .
Lopez M B . Postanaesthetic shivering-from pathophysiology to prevention [J]. Rom J Anaesth Intensive Care , 2018 , 25 ( 1 ): 73 - 81 . DOI: 10.21454/rjaic.7518.251.xum http://dx.doi.org/10.21454/rjaic.7518.251.xum .
Feng G J , Wang Y , Feng J H , et al . The relationship between core temperature and perioperative shivering during caesarean section under intrathecal anesthesia with bupivacaine and ropivacaine: a randomized controlled study [J]. J Anesth , 2021 , 35 ( 6 ): 889 - 895 . DOI: 10.1007/s00540-021-02995-9 http://dx.doi.org/10.1007/s00540-021-02995-9 .
Esmat I M , Mohamed M M , Abdelaal W A , et al . Postspinal anesthesia shivering in lower abdominal and lower limb surgeries: a randomized controlled comparison between paracetamol and dexamethasone [J]. BMC Anesthesiol , 2021 , 21 ( 1 ): 262 . DOI: 10.1186/s12871-021-01483-7 http://dx.doi.org/10.1186/s12871-021-01483-7 .
Zhang H G , Li H L , Zhao S J , et al . Remimazolam in general anesthesia: a comprehensive review of its applications and clinical efficacy [J]. DDDT , 2024 , 18 : 3487 - 3498 . DOI: 10.2147/dDDT.s474854 http://dx.doi.org/10.2147/dDDT.s474854 .
Ferrea G , Monks D T , Singh P M , et al . Comparative efficacy of intravenous treatments for perioperative shivering in patients undergoing caesarean delivery under neuraxial anaesthesia: a systematic review and Bayesian network meta-analysis of randomised-controlled trials [J]. J Clin Anesth , 2025 , 100 : 111680 . DOI: 10.1016/j.jclinane.2024.111680 http://dx.doi.org/10.1016/j.jclinane.2024.111680 .
He T Y , Zhong R P , Zhong W B , et al . Effect of remimazolam on intra-operative hypotension: Systematic review and meta-analysis of randomised controlled trials [J]. Eur J Anaesthesiol , 2024 , 41 ( 12 ): 898 - 909 . DOI: 10.1097/eja.0000000000002057 http://dx.doi.org/10.1097/eja.0000000000002057 .
Cho S A , Lee S J , Kwon W , et al . Effect of remimazolam on the incidence of intraoperative hypothermia compared with inhalation anesthetics in patients undergoing endoscopic nasal surgery: a prospective randomized controlled trial [J]. Int J Med Sci , 2024 , 21 ( 13 ): 2510 - 2517 . DOI: 10.7150/ijms.100262 http://dx.doi.org/10.7150/ijms.100262 .
Lee C , Lee C , Lee H , et al . The effect of remimazolam compared to sevoflurane on postoperative shivering in patients undergoing laparoscopic gynecologic surgery under general anesthesia: a prospective randomized controlled trial [J]. Medicina (Kaunas) , 2023 , 59 ( 3 ): 578 . DOI: 10.3390/medicina59030578 http://dx.doi.org/10.3390/medicina59030578 .
Lee J , Han D W , Kim N Y , et al . Comparison of remimazolam versus sevoflurane on the postoperative quality of recovery in cervical spine surgery: a prospective randomized controlled double-blind trial [J]. Drug Des Devel Ther , 2024 , 18 : 121 - 132 . DOI: 10.2147/DDDT.S441622 http://dx.doi.org/10.2147/DDDT.S441622 .
Bajwa S J , Gupta S , Kaur J , et al . Reduction in the incidence of shivering with perioperative dexmedetomidine: a randomized prospective study [J]. J Anaesthesiol Clin Pharmacol , 2012 , 28 ( 1 ): 86 - 91 . DOI: 10.4103/0970-9185.92452 http://dx.doi.org/10.4103/0970-9185.92452 .
Mittal G , Gupta K , Katyal S , et al . Randomised double-blind comparative study of dexmedetomidine and tramadol for post-spinal anaesthesia shivering [J]. Indian J Anaesth , 2014 , 58 ( 3 ): 257 - 262 . DOI: 10.4103/0019-5049.135031 http://dx.doi.org/10.4103/0019-5049.135031 .
Arif M . Randomized double blind comparison of prophylactic tramadol and tramadol plus ketamine for prevention of shivering after spinal anesthesia in lower segment Caesarian section [J]. J Dow Univ Health Sci , 2024 , 18 ( 1 ): 25 - 31 . DOI: 10.36570/jduhs.2024.1.2007 http://dx.doi.org/10.36570/jduhs.2024.1.2007 .
Zhang Y , Xia F , Zhang W P , et al . Prophylactic ondansetron for preventing intraoperative shivering, nausea and vomiting during spinal anesthesia for cesarean section: a randomized controlled trial [J]. Front Pharmacol , 2024 , 15 : 1500642 . DOI: 10.3389/fphar.2024.1500642 http://dx.doi.org/10.3389/fphar.2024.1500642 .
Mao Y Y , Guo J , Yuan J J , et al . Quality of recovery after general anesthesia with remimazolam in patients undergoing urologic surgery: a randomized controlled trial comparing remimazolam with propofol [J]. Drug Des Devel Ther , 2022 , 16 : 1199 - 1209 . DOI: 10.2147/DDDT.S359496 http://dx.doi.org/10.2147/DDDT.S359496 .
Wiltshire H R , Kilpatrick G J , Tilbrook G S , et al . A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation [J]. Anesth Analg , 2012 , 115 ( 2 ): 284 - 296 . DOI: 10.1213/ANE.0b013e318241f68a http://dx.doi.org/10.1213/ANE.0b013e318241f68a .
Muroya K , Ueda K , Wada K , et al . Novel ultrashort-acting benzodiazepine remimazolam lowers shivering threshold in rabbits [J]. Front Pharmacol , 2022 , 13 : 1019114 . DOI: 10.3389/fphar.2022.1019114 http://dx.doi.org/10.3389/fphar.2022.1019114 .
Nakamura K , Morrison S F . A thermosensory pathway that controls body temperature [J]. Nat Neurosci , 2008 , 11 ( 1 ): 62 - 71 . DOI: 10.1038/nn2027 http://dx.doi.org/10.1038/nn2027 .
Chung S H , Lee B S , Yang H J , et al . Effect of preoperative warming during cesarean section under spinal anesthesia [J]. Korean J Anesthesiol , 2012 , 62 ( 5 ): 454 - 460 . DOI: 10.4097/kjae.2012.62.5.454 http://dx.doi.org/10.4097/kjae.2012.62.5.454 .
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621